Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Background</h3><p>Multiple organ dysfunction syndrome (MODS) occurs in the setting of a variety of pathologies including infection and trauma. Some patients decompensate and require Veno-Arterial extra corporeal membrane oxygenation (ECMO) as a palliating manoeuvre for recovery of cardiopulmonary function. The molecular mechanisms driving progression from MODS to cardiopulmonary collapse remain incompletely understood, and no biomarkers have been defined to identify those MODS patients at highest risk for progression to requiring ECMO support.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Methods</h3><p>Whole blood RNA-seq profiling was performed for 23 MODS patients at three time points during their ICU stay (at diagnosis of MODS, 72 hours after, and 8 days later), as well as four healthy controls undergoing routine sedation. Of the 23 MODS patients, six required ECMO support (ECMO patients). The predictive power of conventional demographic and clinical features was quantified for differentiating the MODS and ECMO patients. We then compared the performance of markers derived from transcriptomic profiling including <a class="workspace-trigger" href="#bib0001">[1]</a> transcriptomically imputed leukocyte subtype distribution, <a class="workspace-trigger" href="#bib0002">[2]</a> relevant published gene signatures and <a class="workspace-trigger" href="#bib0003">[3]</a> a novel differential gene expression signature computed from our data set. The predictive power of our novel gene expression signature was then validated using independently published datasets.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Finding</h3><p>None of the five demographic characteristics and 14 clinical features, including The Paediatric Logistic Organ Dysfunction (PELOD) score, could predict deterioration of MODS to ECMO at baseline. From previously published sepsis signatures, only the signatures positively associated with patient's mortality could differentiate ECMO patients from MODS patients, when applied to our transcriptomic dataset (P-value ranges from 0.01 to 0.04, Student's test). Deconvolution of bulk RNA-Seq samples suggested that lower neutrophil counts were associated with increased risk of progression from MODS to ECMO (P-value = 0.03, logistic regression, OR=2.82 [95% CI 0.63 - 12.45]). A total of 30 genes were differentially expressed between ECMO and MODS patients at baseline (log2 fold change ≥ 1 or ≤ -1 with false discovery rate ≤ 0.01). These genes are involved in protein maintenance and epigenetic-related processes. Further univariate analysis of these 30 genes suggested a signature of seven DE genes associated with ECMO (OR > 3.0, P-value ≤ 0.05, logistic regression). Notably, this contains a set of histone marker genes, including <em>H1F0, HIST2H3C, HIST1H2AI, HIST1H4, HIST1H2BL</em> and <em>HIST1H1B</em>, that were highly expressed in ECMO. A risk score derived from expression of these genes differentiated ECMO and MODS patients in our dataset (AUC = 0.91, 95% CI 0.79-1.00, P-value = 7e-04, logistic regression) as well as validation dataset (AUC= 0.73, 95% CI 0.53-0.93, P-value = 2e-02, logistic regression).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Interpretation</h3><p>This study demonstrates that transcriptomic features can serve as indicators of severity that could be superior to traditional methods of ascertaining acuity in MODS patients. Analysis of expression of signatures identified in this study could help clinicians in the diagnosis and prognostication of MODS patients after arrival to the Hospital.</p>

Expression and Relationship of PPARγ and COX-2 in Peripheral Blood Mononuclear Cells of Multiple Organ Dysfunction Syndrome Patients

Expression and relationship of PPARγand NF -κB in peripheral blood mononuclear cells of multiple organ dysfunction syndrome patients

Potential Role of Phosphodiesterases in the Development of Multiple Organ Dysfunction

Correlation between protein C-1641A/-1654C haplotype and coagulation disorder in sepsis

Multi-center Clinical Study on the Diagnostic Criteria for Multiple Organ Dysfunction Syndrome with Illness Severity Score System

Endothelial Progenitor Cells Modulated by IL-1β in Multiple Organ Dysfunction Syndrome in Porcine

COX-2 optimizes cardiac mitochondrial biogenesis and exerts a cardioprotective effect during sepsis

An Experimental Study on Insulin Combined with Ethyl Pyruvate in Treatment of MODS Rats with Inflammato-ry Response and Oxidative Stress after Severe Burns

Study on multiple organ dysfunction syndrome scoring system in evaluating prognosis of patients with MODS

[Clinical Epidemiology of 1,087 Patients with Multiple Organ Dysfunction Syndrome].

Clinical Study of Plasma Cytokines in the Elderly Critical Patients with Multiple Organ Dysfunction Syndrome

[Inhibitory effect and mechanism of bone marrow mesenchymal stem cells on inflammation in rats with multiple organ dysfunction syndrome]

Paracoxib Alleviates Ventilator-Induced Lung Injury Through Functional Modulation of Lung-Recruited CD11b<SUP>lo</SUP>Ly6C<SUP>hi</SUP> Monocytes

Risk Factors for Multiple Organ Dysfunction Syndrome in Severe Stroke Patients

Clinical epidemiology of 1087 patients with multiple organ dysfunction syndrome

Gene expression signatures identify paediatric patients with multiple organ dysfunction who require advanced life support in the intensive care unit

Epidemiology of Acute Respiratory Distress Syndrome in the Patients with Multiple Organ Dysfunction Syndrome in China:Analyse of the 1087 MODS Patients with the Multi-Centered,prospective Method

Clinical Study of the Impact of a History of Chronic Diseases on the Mortality of Patients with Multiple Organ Dysfunction Syndrome in the Elderly

[Scoring System to Measure the Severity of the Multiple Organ Dysfunction Syndrome].

Clinical effect of immune regulation therapy on severe sepsis and MODS patients

[Modulation of Endothelial Progenitor Cells by Tumor Necrosis Factor-Α in Multiple Organ Dysfunction Syndrome in Swine].